Gufic Biosciences (GUFICBIO) | Stock Overview & Key Data
Gufic Biosciences Performance Comparison
Stock Range
Today's Range
Low: ₹355.50
High: ₹369.00
on August 18, 2025
52 Week Range
Low: ₹298.80
High: ₹504.25
on April 7, 2025
on November 8, 2024
All-Time High: ₹26,990.00 on October 30, 2023
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR35.7B
EPS
6.95
P/E Ratio (TTM)
51.29
Forward P/E
N/A
P/B Ratio
5.95
PEG Ratio
N/A
Div. Yield
0.03%
ROE
11.59%
Beta
0.140
Debt to Equity
55.93
Financial Highlights
Profitability
Gross Margin
56.26%
Operating Margin
11.44%
Profit Margin
7.36%
Returns and Earnings
Return on Assets (TTM)
5.96%
Return on Equity (TTM)
11.59%
EBITDA
INR1.4B
Net Income (TTM)
INR618.6M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR83.84
Quarterly Revenue Growth (YoY)
10.30%
Quarterly Earnings Growth (YoY)
-37.30%
Dividend Information
Last 12-Month Dividend
₹0.10
Current Dividend Yield
0.03%
3-Year Average Dividend Yield
0.04%
3-Year Average Annual Dividend
₹0.13
3-Year Total Dividends
₹0.40
Ex-Dividend Date
September 17, 2024
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Gufic Biosciences GUFICBIO | 35.75B Small-cap | -1.16% | 0.56% | -5.54% | -11.25% | -21.91% | 3.12% | 77.94% | 287.71% |
| Sun Pharmaceutical SUNPHARMA | 3.94T Large-cap | 2.69% | -2.45% | -3.91% | -3.48% | -13.15% | -5.82% | 82.10% | 208.33% |
| Divi's Laboratories DIVISLAB | 1.63T Large-cap | 0.02% | -9.53% | -1.34% | 4.94% | 0.98% | 32.34% | 65.91% | 88.85% |
| Sun Pharma Advanced SPARC | 45.51B Small-cap | -3.92% | -13.01% | -6.93% | -0.76% | -30.12% | -34.25% | -41.92% | -22.97% |
| Aarti Drugs AARTIDRUGS | 44.42B Small-cap | -3.86% | 1.23% | 5.23% | 18.26% | 6.84% | -2.04% | 8.97% | -37.88% |
| Sequent Scientific SEQUENT | 43.92B Small-cap | 0.45% | -5.27% | 0.82% | 19.96% | -4.81% | 22.66% | 59.79% | 34.23% |
Ownership & Short Interest
Insider Ownership
77.53%
Institutional Ownership
3.48%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
43K
Average 90-Day Volume
63K
Gufic Biosciences Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Gufic Biosciences would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is GUFICBIO's 52-week high and low?
- In the last 52 weeks, Gufic Biosciences reached a high of ₹504.25 (on November 8, 2024) and a low of ₹298.80 (on April 7, 2025).
- What is the market cap and P/E ratio for GUFICBIO?
- Curious about Gufic Biosciences's size and valuation? Its market capitalization stands at 35.75B. When it comes to valuation, the P/E ratio (trailing twelve months) is 51.29, and the forward P/E (looking ahead) is N/A.
- Does GUFICBIO pay dividends? If so, what's the yield?
- Yes, Gufic Biosciences is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.03%, and the company has paid an average of ₹0.13 per share annually over the past 3 years.
- Who are Gufic Biosciences's main competitors or similar companies to consider before investing?
When looking at Gufic Biosciences, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Sun Pharmaceutical
SUNPHARMA3.94T Healthcare Drug Manufacturers - Specialty & Generic -5.82% 82.10% Divi's Laboratories
DIVISLAB1.63T Healthcare Drug Manufacturers - Specialty & Generic 32.34% 65.91% Sun Pharma Advanced
SPARC45.51B Healthcare Drug Manufacturers - Specialty & Generic -34.25% -41.92% Aarti Drugs
AARTIDRUGS44.42B Healthcare Drug Manufacturers - Specialty & Generic -2.04% 8.97% Sequent Scientific
SEQUENT43.92B Healthcare Drug Manufacturers - Specialty & Generic 22.66% 59.79% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Gufic Biosciences Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Gufic Biosciences's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 11.59%, the Debt to Equity ratio from the most recent quarter is 55.93, and its Gross Profit Margin stands at 56.26%.
- What is the recent revenue and earnings growth for GUFICBIO?
- Looking at Gufic Biosciences's growth, its revenue over the trailing twelve months (TTM) was INR8B. Compared to the same quarter last year (YoY), quarterly revenue grew by 10.30%, and quarterly earnings saw a YoY growth of -37.30%.
- How much of GUFICBIO stock is held by insiders and institutions?
- Wondering who owns Gufic Biosciences stock? Company insiders (like executives and directors) hold about 77.53% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 3.48%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.